Cargando…

The Synergistic Effect of Exogenous Glutamine and Rifampicin Against Mycobacterium Persisters

Persisters, stochastic dormant variants of normal bacteria cell, represent a significant portion of the survivors upon exposure to antibiotics and other environmental stresses, which contributes substantially to high level antibiotics tolerance. Glutamine is a crucial component of the Mycobacteria n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xue, Duan, Xiangke, Li, Jiang, Niu, Jingjing, Yuan, Siqi, Wang, Xiaoyu, Lambert, Nzungize, Li, Xue, Xu, Junqi, Gong, Zhen, Yan, Shuangquan, Xie, Longxiang, Xie, Jianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062616/ https://www.ncbi.nlm.nih.gov/pubmed/30079057 http://dx.doi.org/10.3389/fmicb.2018.01625

Ejemplares similares

Mycobacterium tuberculosis PE31 (Rv3477) Attenuates Host Cell Apoptosis and Promotes Recombinant M. smegmatis Intracellular Survival via Up-regulating GTPase Guanylate Binding Protein-1
por: Ali, Md Kaisar, et al.
Publicado: (2020)

Interleukin-10 Family and Tuberculosis: An Old Story Renewed
por: Abdalla, Abualgasim Elgaili, et al.
Publicado: (2016)

Mycobacterium tuberculosis Rv0341 Promotes Mycobacterium Survival in In Vitro Hostile Environments and within Macrophages and Induces Cytokines Expression
por: Abdalla, Abualgasim Elgaili, et al.
Publicado: (2020)

A Glutamine Insertion at Codon 432 of RpoB Confers Rifampicin Resistance in Mycobacterium tuberculosis
por: Lai, Li-Yin, et al.
Publicado: (2020)

Synergistic Response of Rifampicin with Hydroperoxides on Mycobacterium: A Mechanistic Study
por: Patel, Yesha S., et al.
Publicado: (2017)

Prophage-like elements present in Mycobacterium genomes
por: Fan, Xiangyu, et al.
Publicado: (2014)

ArsR Family Regulator MSMEG_6762 Mediates the Programmed Cell Death by Regulating the Expression of HNH Nuclease in Mycobacteria
por: Duan, Xiangke, et al.
Publicado: (2022)

Mycobacterium tuberculosis Rv0580c Impedes the Intracellular Survival of Recombinant Mycobacteria, Manipulates the Cytokines, and Induces ER Stress and Apoptosis in Host Macrophages via NF-κB and p38/JNK Signaling
por: Ali, Md Kaisar, et al.
Publicado: (2021)

Biology of IL-27 and its Role in the Host Immunity against Mycobacterium Tuberculosis
por: Abdalla, Abualgasim Elgaili, et al.
Publicado: (2015)

Comprehensive analysis of protein acetyltransferases of human pathogen Mycobacterium tuberculosis
por: Xie, Longxiang, et al.
Publicado: (2019)

Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation
por: Mori, Maiko, et al.
Publicado: (2014)

Exogenous Glutamine in Respiratory Diseases: Myth or Reality?
por: Oliveira, Gisele P., et al.
Publicado: (2016)

Mycobacterium tuberculosis Rv1152 is a Novel GntR Family Transcriptional Regulator Involved in Intrinsic Vancomycin Resistance and is a Potential Vancomycin Adjuvant Target
por: Zeng, Jie, et al.
Publicado: (2016)

Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis
por: Yelamanchi, Soujanya D., et al.
Publicado: (2022)

Rifampicin-resistant Mycobacterium leprae in an elderly leprosy patient in the people’s Republic of China
por: Yu, Meiwen, et al.
Publicado: (2013)

Exogenous Citrulline and Glutamine Contribute to Reverse the Resistance of Salmonella to Apramycin
por: Yong, Yan, et al.
Publicado: (2021)

Proteasome Accessory Factor C (pafC) Is a novel gene Involved in Mycobacterium Intrinsic Resistance to broad-spectrum antibiotics - Fluoroquinolones
por: Li, Qiming, et al.
Publicado: (2015)

The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance
por: Lake, M. Alexandra, et al.
Publicado: (2023)

Accurate Detection of Rifampicin-Resistant Mycobacterium Tuberculosis Strains
por: Song, Keum-Soo, et al.
Publicado: (2016)

Interpreting very low Mycobacterium tuberculosis detected on Xpert Mycobacterium tuberculosis/rifampicin
por: Ajbani, Kanchan, et al.
Publicado: (2019)

Identification of Potential Biomarkers and Related Transcription Factors in Peripheral Blood of Tuberculosis Patients
por: Xie, Longxiang, et al.
Publicado: (2020)

Mycobacterium Lysine ε-aminotransferase is a novel alarmone metabolism related persister gene via dysregulating the intracellular amino acid level
por: Duan, Xiangke, et al.
Publicado: (2016)

Regional distribution of Mycobacterium tuberculosis infection and resistance to rifampicin and isoniazid as determined by high-resolution melt analysis
por: Wang, Zhenzhen, et al.
Publicado: (2022)

Cell wall inhibitors increase the accumulation of rifampicin in Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2019)

Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Khan, Anwar Sheed, et al.
Publicado: (2021)

The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease
por: Schildkraut, Jodie A., et al.
Publicado: (2023)

Mycobacterium shinjukuense infection successfully treated with clarithromycin, rifampicin, and ethambutol
por: Nakamura, Kayo, et al.
Publicado: (2023)

Increased Ammonium Toxicity in Response to Exogenous Glutamine in Metastatic Breast Cancer Cells
por: Kiesel, Violet A., et al.
Publicado: (2022)

A Novel marRAB Operon Contributes to the Rifampicin Resistance in Mycobacterium smegmatis
por: Zhang, Haiwei, et al.
Publicado: (2014)

Trisubstituted Imidazoles as Mycobacterium tuberculosis Glutamine Synthetase Inhibitors†
por: Gising, Johan, et al.
Publicado: (2012)

In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Efficacy and role of Xpert(®) Mycobacterium tuberculosis/rifampicin assay in urinary tuberculosis
por: Samuel, Benedict Paul, et al.
Publicado: (2018)

Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi
por: Chikaonda, Tarsizio, et al.
Publicado: (2017)

Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
por: Kim, Hyung-Jun, et al.
Publicado: (2019)

Rifampicin resistance in Mycobacterium tuberculosis in Iran: a two-centre study
por: Bahraminia, F., et al.
Publicado: (2021)

Mycobacterium Fluoroquinolone Resistance Protein D (MfpD), a GTPase-Activating Protein of GTPase MfpB, Is Involved in Fluoroquinolones Potency
por: Huang, Yu, et al.
Publicado: (2022)

Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed rpoB Mutations and Discordant Susceptibility Phenotypes
por: Wang, Wei, et al.
Publicado: (2022)

MazEF-rifampicin interaction suggests a mechanism for rifampicin induced inhibition of persisters
por: Alexander, Cyrus, et al.
Publicado: (2020)

Hypoxic Non-replicating Persistent Mycobacterium tuberculosis Develops Thickened Outer Layer That Helps in Restricting Rifampicin Entry
por: Jakkala, Kishor, et al.
Publicado: (2019)

Integrated metabolomic and transcriptomic analyses of the synergistic effect of polymyxin–rifampicin combination against Pseudomonas aeruginosa
por: Mahamad Maifiah, Mohd Hafidz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q2n83g12um0p1qflg6cclksfr2